Lets all work together to keep the spirit of Dominick Luchesi going by passing his story on, and helping to make people aware of this rare and aggressive cancer. Lets work together to support the causes, hospitals, and doctors that are fighting and researching a cure for this cancer.
Desmoplastic small round blue cell cancer is a silent disease that hides itself and grows at an aggressive speed. In most all cases, this cancer does not show itself until it is in the latest stages, and this is only due to other complications caused by the tumor(s).
We hope we can all work together in moving towards a cure for this cancer, better treatments, or maybe some way to identify the cancer at very early stages.
Information on this Cancer:
Desmoplastic Small Round Cell Tumor
(Information from St Jude Children’s Research Hospital)
Desmoplastic small round cell tumor is a highly aggressive tumor that frequently occurs as multiple masses in the abdomen involving the regional lymph nodes and the lining of the abdomen and pelvis.
The most common symptoms include abdominal pain, abdominal mass and symptoms of gastrointestinal obstruction.
Paratesticular, ovarian, parotid gland, brain and thoracic primary tumors have also been described. The most common sites of spread are the liver, lungs and bones.
The cell of origin for this tumor is unclear. The tumor shows characteristics of epithelial, mesenchymal and neural differentiation. A characteristic translocation between chromosome 11 and 22 has been associated with desmoplastic small round cell tumors involving the EWS and WT1 genes. How this translocation contributes to the pathogenesis of this tumor is under active study. However, the identification of this gene abnormality has been very useful in the confirming the diagnosis of this tumor.
Desmoplastic small round cell tumor is extremely rare.
This tumor predominately affects males, usually in their second decade of life.
No environmental or familial risk factors have been identified for this tumor.
Overall survival rates for desmoplastic small round cell tumors is poor, less than 20 percent. Patients with localized disease outside of the abdomen and pelvis seem to have a better prognosis.
Because of diffuse involvement of the abdomen at the time of diagnosis, complete resection of this tumor is rarely possible.
Effective treatment must rely upon chemotherapy and radiation therapy.
Recent reports suggest that multimodal therapy including surgical debulking, radiotherapy and high dose chemotherapy may improve survival in a subset of patients with desmoplastic small round cell tumor.
Clearly, new therapeutic strategies are needed for this aggressive tumor.